Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Irritable Bowel Syndrome
NCT03613545Phase 3Recruiting
- Sponsor
- Guangzhou First People's Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in irritable bowel syndrome (IBS), sponsored by Guangzhou First People's Hospital. Started Aug 2018; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03613545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613545.